Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow TransplantationMohamad Mohty, Rafael F. Duarte, Kai Hübel et al.|Bone Marrow Transplantation|2014Cited by 192
Secondary solid cancer screening following hematopoietic cell transplantationYoshihiro Inamoto, Navneet S. Majhail, Grzegorz Basak et al.|Bone Marrow Transplantation|2015Cited by 185
European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilizationKai Hübel, Rafael F. Duarte, M M Fresen et al.|Bone Marrow Transplantation|2011Cited by 65
Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide studyLidia Gil, K Czyźewski, Jan Styczyński et al.|Annals of Hematology|2019Cited by 49
Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or LenalidomideFlorent Malard, Rafael F. Duarte, Nicolaus Kröger et al.|Biology of Blood and Marrow Transplantation|2011Cited by 44